Physician profile
Todd Hrabak
NPI 1801821152
$401,131.94
in general payments reported to CMS, 2019-2025
41 companies · $179K in 2025
The $179K reported for 2025 was more than what 99% of Allergy providers received nationally (typical 2025 total: $1,129).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $16K · 2021: $16K · 2022: $42K · 2023: $59K · 2024: $59K · 2025: $179K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $232K · Travel and Lodging: $50K · Food and Beverage: $15K · Consulting Fee: $287 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $231,934.44 |
| Travel and Lodging | $49,762.97 |
| Food and Beverage | $15,252.84 |
| Consulting Fee | $286.94 |
| Education | $168.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $156,295.01 | 2019-2025 | Hizentra, Haegarda |
| Takeda Pharmaceuticals U.S.A., INC. | $144,122.04 | 2020-2025 | Cuvitru, Hyqvia, Glassia |
| Ars Pharmaceuticals Operations, INC. | $62,695.23 | 2025 | Neffy |
| Bio Products Laboratory USA, INC. | $12,332.18 | 2022-2023 | Gammaplex, Coagadex |
| Shire North American Group INC | $8,607.36 | 2019 | |
| Gc Biopharma USA, INC. | $2,908.62 | 2024-2025 | Alyglo, Alyglo |
| Novartis Pharmaceuticals Corporation | $2,875.45 | 2019-2025 | |
| Genentech USA, INC. | $1,755.61 | 2019-2025 | Xolair |
| Glaxosmithkline, LLC. | $1,725.02 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $1,361.85 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Genzyme Corporation | $1,272.42 | 2019-2025 | |
| Grifols USA, LLC | $934.33 | 2019-2025 | Xembify, Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $572.00 | 2019-2024 | Spiriva Respimat, Stiolto Respimat, Ofev |
| Regeneron Healthcare Solutions, INC. | $490.87 | 2019-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $487.45 | 2019-2024 | Uptravi, Opsumit |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $427.34 | 2020-2025 | |
| Electromed, INC. | $330.76 | 2021-2025 | Smartvest |
| Adma Biomanufacturing LLC | $309.90 | 2020-2025 | |
| Pharming Healthcare, INC. | $237.22 | 2021-2025 | Ruconest |
| Optinose US, INC. | $144.64 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $132.65 | 2019-2022 | |
| Amgen INC. | $107.82 | 2019-2025 | |
| Octapharma USA, INC. | $102.12 | 2021-2024 | Octagam Immune Globulin (Human) |
| Baxter Healthcare | $99.11 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Abbott Laboratories | $97.25 | 2019-2024 | Proclaim, Prodigy |
| Abbvie INC. | $91.42 | 2021-2023 | |
| Boston Scientific Corporation | $79.29 | 2019-2024 | |
| Philips North America LLC | $73.13 | 2019-2024 | (8874) Incourage |
| Kedrion Biopharma, INC. | $58.24 | 2023-2024 | Koate, Gammaked, Kedrab |
| Kaleo, INC. | $56.09 | 2022 | |
| Advanced Respiratory, INC | $55.87 | 2020-2021 | |
| Blueprint Medicines Corporation | $51.47 | 2023-2024 | Ayvakit |
| United Therapeutics Corporation | $49.17 | 2021-2024 | |
| Phadia US INC. | $36.98 | 2022-2024 | Immunocap |
| Merck Sharp & Dohme LLC | $35.72 | 2024-2025 | Capvaxive, Vaxneuvance, Gardasil |
| Biocryst US Sales Co., LLC | $32.10 | 2024 | Orladeyo |
| Springworks Therapeutics, INC. | $22.12 | 2025 | Gomekli |
| Inogen, INC. | $20.10 | 2024 | |
| Mylan Specialty L.P. | $19.77 | 2022 | |
| Insmed, INC. | $13.32 | 2024 | Arikayce |
| Aimmune Therapeutics, INC. | $12.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Hrabak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.